¹Ì±¹ FDA cGMP ´ëÀÀ½Ç¹«(18³â1Â÷)
¹Ì±¹ FDAµî·Ï ÀÎÁõ±³À°À» ÅëÇØ, ¹Ì±¹ÀÇ ÀÎÁõÁ¦µµ¸¦ ÀÌÇØÇÏ°í Ç°Áú°ü¸® ½Ã½ºÅÛÀÎ FDA cGMP¿¡¼ ¿ä±¸ÇÏ´Â ½ÃÇè°Ë»ç ¿ä±¸»çÇ×ÀÌ ¹«¾ùÀÎÁö ÆľÇÇÏ¿©, Ç°ÁúÀ» À¯ÁöÇϱâ À§ÇØ cGMP¸¦ °ü¸® ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ¹è¾çÇÏ´Â ½Ç¹«±³À°À» ´ÙÀ½°ú °°ÀÌ ½Ç½ÃÇÕ´Ï´Ù.
- ´Ù À½ -
1. °ú Á¤ ¸í : ¹Ì±¹ FDA cGMP ´ëÀÀ½Ç¹«
2. ±³À°±â°£ : 2018. 05. 10. ~ 2018. 05. 11. (14½Ã°£)
3. ° »ç : Áö¿¥¿¡½ºÄÁ¼³Æà ½Å±Ôö ºÎ´ëÇ¥
4. ±³À°Àοø : 20¿©¸í
5. ±³À°Àå¼Ò : Çѱ¹ÀÇ·á±â±â°ø¾÷Çùµ¿Á¶ÇÕ °ÀÇÀå (2,6È£¼± ½Å´ç¿ª 3¹ø Ãⱸ
6. ±³ À° ºñ : Çù¾à±â¾÷¿¡ ÇÑÇؼ ¹«·á(ºñÇù¾à±â¾÷ ¼ö°ºÒ°¡)
- ¹«´ÜºÒÂü½Ã ´ÙÀ½±³À°Âü¿©¿¡ Á¦ÇÑÀ» µÓ´Ï´Ù.
- Çù¾à±â¾÷È®ÀÎ : http://www.medihrd.or.kr/apply/partner_list.php
(¸®½ºÆ®¿¡ ȸ»ç¸íÀÌ ÀÖÀ¸¸é Çù¾à±â¾÷À̸çÁ¶ÇÕȸ¿ø»ç ¿©ºÎ¿Í °ü°è¾øÀÌ ¹«·áÀÔ´Ï´Ù.)
- Çù¾àü°á¾È³» : http://www.medihrd.or.kr/about/argeement.php
- ±³À°È¨ÆäÀÌÁö :http://www.medihrd.or.kr/
ÀÏÀÚ |
½Ã°£ |
°»ç |
±³À°³»¿ë |
1ÀÏÂ÷ |
09:30~10:30 |
Áö¿¥¿¡½º ÄÁ¼³Æà ½Å±Ôö ºÎ´ëÇ¥ |
¹Ì±¹ cGMP Inspection ÇÁ·Î¼¼½º |
10:30~£±1:30 |
21 CFR Part 820-Management Control | ||
11:30~12:30 |
Áß ½Ä | ||
12:30~13:30 |
21 CFR Part 820-Management Control | ||
13:30~15:30 |
21 CFR Part 820-Corrective and Preventive Actions | ||
15:30~16:30 |
21 CFR Part 820-Production and Process Controls | ||
16:30~17:30 |
21 CFR Part 820-Facilities and Controls | ||
2ÀÏÂ÷ |
09:30~10:30 |
Áö¿¥¿¡½ºÄÁ¼³Æà ½Å±Ôö ºÎ´ëÇ¥ |
21 CFR Part 820-Material Controls |
10:30~11:30 |
21 CFR Part 820-Documents/Records/Change Control | ||
11:30~12:30 |
Áß ½Ä | ||
12:30~13:30 |
¹Ì±¹ eMDR µî·Ï ÇÁ·Î¼¼½º | ||
13:30~15:30 |
Á¦Ç°À̷±â·Ï(DHR) ÀÛ¼º »ç·Ê ¿¬±¸ | ||
15:30~17:30 |
483 Observation ÈļÓÁ¶Ä¡ »ç·Ê¿¬±¸ |
▸ ±³À°Àå¼Ò
▸±³À°±â°£ Áß ÁÖÂ÷°¡ ºÒ°¡ÇÕ´Ï´Ù.
´ëÁß±³ÅëÀ» ÀÌ¿ëÇÏ¿© ±³À°¿¡ Âü¼®ÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
(ÀαÙÁÖÂ÷Àå ÀÌ¿ë ½Ã ÁÖÂ÷ºñ ±³À°»ý ºÎ´ã)
▸ÁÖ ¼Ò : ¼¿ïƯº°½Ã Áß±¸ Åð°è·Î 450 ½Å¿µºôµù 7Ãþ
▸´ëÁß±³Åë : 2, 6È£¼± ½Å´ç¿ª 3¹ø Ãⱸ
▸ÀαÙÁÖÂ÷Àå¾È³»
- Áß±¸°ø¿µÁÖÂ÷ÀåÀ§Ä¡¾È³»
ȨÆäÀÌÁö : www.e-junggu.or.kr/new/parking/publicParking/facilities.asp